Therapeutic Nanoparticle Companies Are Rare: Meet the CEO of One of Them
In our last BIO Europe interview, I caught up with CEO Timm Jessen of Topas…
15/11/2017 - 4 minutes
In our last BIO Europe interview, I caught up with CEO Timm Jessen of Topas…
Topas Therapeutics received an extra €4M from Boehringer Ingelheim Venture Fund to help its autoimmune disease candidates…
Topas Therapeutics has signed a multi-year agreement with Eli Lilly to develop drug candidates for…
Evotec (Germany) has launched a spin-off, Topas Therapeutics, to create nanoparticle-based therapeutics to treat immunological disorders.…